Advertisement

Topics

"Global Musculoskeletal Partnering 2012 2018 Updated Deal Trends" Drugs and Medication Database

19:47 EDT 19th March 2019 | BioPortfolio

Here are the most relevant "Global Musculoskeletal Partnering 2012 2018 Updated Deal Trends" Drugs and Medications that we have found in our database.

More Information about "Global Musculoskeletal Partnering 2012 2018 Updated Deal Trends" on BioPortfolio

We have published hundreds of Global Musculoskeletal Partnering 2012 2018 Updated Deal Trends news stories on BioPortfolio along with dozens of Global Musculoskeletal Partnering 2012 2018 Updated Deal Trends Clinical Trials and PubMed Articles about Global Musculoskeletal Partnering 2012 2018 Updated Deal Trends for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Global Musculoskeletal Partnering 2012 2018 Updated Deal Trends Companies in our database. You can also find out about relevant Global Musculoskeletal Partnering 2012 2018 Updated Deal Trends Drugs and Medications on this site too.

Showing "Global Musculoskeletal Partnering 2012 2018 Updated Deal Trends" Drugs and Medications 1–25 of 75

Possibly Relevant

Oxygen [rotech healthcare inc]

2018 DRUG REGISTRATION LISTING

Cpda-1 [fenwal, inc.]

CPDA-1 BLOOD-PACK™ Unit

Cpda-1 [fenwal, inc.]

Triple Blood-Pack™ Unit Anticoagulant Citrate Phosphate Dextrose Adenine Solution (CPDA-1)

Nitrogen [fullerton welding supply]

Nitrogen 2

Nitrogen [fullerton welding supply]

Nitrogen

Cpda-1 [fenwal, inc.]

Cpda-1 [fenwal, inc.]

Anticoagulant Citrate Phosphate Dextrose Adenine Solution, USP (CPDA-1) BLOOD-PACK™ Unit

Iclusig [millennium pharmaceuticals, inc.]

These highlights do not include all the information needed to use ICLUSIG safely and effectively. See full prescribing information for ICLUSIG. ICLUSIG(ponatinib) tablets, for oral use Initial U.S. Approval: 2012

Betamethasone dipropionate [glenmark pharmaceuticals inc., usa]

These highlights do not include all the information needed to use BETAMETHASONE DIPROPIONATE CREAM safely and effectively. See full prescribing information for BETAMETHASONE DIPROPIONATE CREAM. BETAMETHASONE DIPROPIONATE cream, 0.05% (Augmented*) for topi

Bss [alcon laboratories, inc.]

BSS Sterile Irrigating Solution(balanced salt solution)

Carbamazepine [aidarex pharmaceuticals llc]

These highlights do not include all the information needed to use carisoprodol safely and effectively. See full prescribing information for carisoprodol tablets, USP. Carisoprodol Tablets, USP for Oral use CIVInitial U.S. Approval: 1959

Betamethasone dipropionate [preferred pharmaceuticals inc., usa]

These highlights do not include all the information needed to use BETAMETHASONE DIPROPIONATE CREAM safely and effectively. See full prescribing information for BETAMETHASONE DIPROPIONATE CREAM. BETAMETHASONE DIPROPIONATE cream, 0.05% (Augmented*) for topi

Betamethasone dipropionate [a-s medication solutions]

These highlights do not include all the information needed to use BETAMETHASONE DIPROPIONATE CREAM safely and effectively. See full prescribing information for BETAMETHASONE DIPROPIONATE CREAM. BETAMETHASONE DIPROPIONATE cream, 0.05% (Augmented*) for topi

Cpda-1 [fenwal, inc.]

Double Blood-Pack™ Unit Anticoagulant Citrate Phosphate Dextrose Adenine Solution (CPDA-1)

Tobrex [alcon laboratories, inc.]

TOBREX (tobramycin ophthalmic solution) 0.3%

Fenofibrate [northwind pharmaceuticals]

NA

Sulfamethoxazole and trimethoprim [aurobindo pharma limited]

NA

Cpd/adsol [fenwal, inc.]

NA

Cpda-1 [fenwal, inc.]

Double Blood-Pack™ Unit Anticoagulant Citrate Phosphate Dextrose Adenine Solution (CPDA-1)

Proparacaine hydrochloride [sandoz inc.]

Proparacaine Hydrochloride Ophthalmic Solution USP, 0.5%

Condylox [allergan, inc.]

Physician Information Condylox Gel 0.5% (podofilox gel) (con' de lox) Content Updated: May 2018 Rx only

Adsol red cell preservation solution system in plastic container (pl 146 plastic) [fenwal, inc.]

Diclofenac sodium [dispensing solutions, inc.]

Diclofenac Sodium Delayed-release Tablets, USP 40-9184 Revised – June 2012

Diclofenac sodium [blenheim pharmacal, inc]

Diclofenac Sodium Delayed-release Tablets, USP 40-9184 Revised – June 2012

Mytesi [napo pharmaceuticals, inc.]

These highlights do not include all the information needed to use MYTESI safely and effectively . See full prescribing information for MYTESI.       MYTESI (crofelemer) delayed-release tablets for oral use      Initial U.S. Approval: 2012



Advertisement
Quick Search
Advertisement
Advertisement